Ex Parte Application by Shira Israella Klein-Bentsur to take discovery from Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank N.A., HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, N.A., Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, N.A., RBC Capital Markets, and Cornick, Garber & Sandler, LLP for use in legal proceedings in Israel involving Ron Bentsur, filed at the U. S. District Court for the Southern District of New York.
247
November 28, 2018
Shira Israella Klein-Bentsur
Xx Xx Xx
Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank NA, HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, NA, Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, NA, RBC Capital Markets, Cornick, Garber & Sandler, LLP
Topics
Israel USAKeywords
ABN Amro Banco Santander Bank Leumi Bank of Ireland Bank of New York Mellon